Circulation. 1996;93:2088
(Circulation. 1996;93:2088.)
© 1996 American Heart Association, Inc.
Recurrent Thrombosis of Bileaflet Prosthetic Valves
Rafael Hirsch, MD;
Alejandro Soldky, MD
From the Heart Institute, Rabin Medical Center, Beilinson Campus,
Petah-Tiqva, Israel.
Correspondence to Rafael Hirsch, MD, The Heart Institute, Rabin Medical Center, Beilinson Campus, Petah Tiqva 49100, Israel.
 |
Introduction
|
|---|
A 48-year-old
man with rheumatic heart disease had aortic and
mitral valve
replacement with bileaflet Carbomedix valves. Two
months later,
he presented in shock with acute thrombosis of
the mitral valve, which
was replaced with another bileaflet
valve in an emergency operation.
Three months later, he complained
of shortness of breath and was found
on Doppler echocardiography
to have impaired ventricular function and a
calculated peak
instantaneous gradient of 100 mm Hg through the
prosthetic aortic
valve. Fluoroscopy in the right anterior oblique
projection
(a, systolic frame; b, diastolic frame) showed an immobile
anterior
leaflet of the aortic prosthesis in a nearly closed position
and
restricted movement of the posterior leaflet. Systolic
color-Doppler
flow signal through the prosthetic valve in the
horizontal-plane
transesophageal echocardiogram (c and d) had an
unusual semicircular
shape, the blocked anterior leaflet remaining
"colorless." There
was also mild aortic regurgitation through the
posterior leaflet
(not shown). The patient declined thrombolytic
therapy, and
in an effort to prevent another operation, he was treated
in
the intensive care unit with heparin. A week later, repeated
fluoroscopy
showed almost normal motion of the previously stuck
anterior
leaflet but no change in the restricted posterior leaflet.
Ventricular
function improved, but the valve remained stenotic, and the
patient
underwent reoperation. The excised valve shows small but firmly
adherent
thrombi around the leaflet hinges bilaterally, on both the
aortic
(e) and ventricular (f) sides of the valve. No hypercoagulation
disorder
was identified, and the patient is now on a combination of
warfarin,
. . . [Full Text of this Article]